drugset / Trial / NCT01904162
Effect of Age and Gender on the PK and Tolerability of Finafloxacin
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Previous clinical studies have indicated that finafloxacin is well-tolerated with few treatment-related adverse events. As a part of the clinical development of finafloxacin, other PK studies are required to determine the effect of other variables on the PK profile of finafloxacin. This study aims to determine the effect of age and gender on the pharmacokinetic profile of finafloxacin.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Finafloxacin | Small molecule | 400 mg | — |
Indications
No indication recorded.